James Edward Signorovitch
James Edward Signorovitch publishes mostly in Pulmonary and Respiratory Medicine, Molecular Biology and Oncology, on topics such as Muscle Physiology and Disorders, Renal cell carcinoma treatment and Economic and Financial Impacts of Cancer.
- World rank
- #877,111 of 7,710,434 ranked researchers
- Rank in United States
- #290,039 of 1,627,098
- Works
- 439
- Citations
- 8.8k
- Citations per work
- 20.0
What does James Edward Signorovitch research?
James Edward Signorovitch's work is mostly in Medicine (28%), Biochemistry, Genetics and Molecular Biology (9%), Economics, Econometrics and Finance (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else25257.4%
- Health Sciences12227.9%
- Medicine12227.9%
- Life Sciences398.8%
- Social Sciences265.9%
- 1Pulmonary and Respiratory Medicine10% of their works
- 2Molecular Biology9% of their works
- 3Oncology7% of their works
- 4Economics and Econometrics6% of their works
- 5Cardiology and Cardiovascular Medicine6% of their works
- 6Hematology5% of their works
Research topics
Which keywords describe James Edward Signorovitch's research?
The keywords of their largest research topics: Quality of Life, Metastatic Breast Cancer, Muscle Regeneration, Skeletal Muscle Atrophy, Metastatic, Renal Cell Carcinoma, Cost of Care and Financial Toxicity.
- Taxanes
- Targeted Therapy
- CDK4/6 Inhibitors
- Health Utility Measures
- Imatinib
- Financial Toxicity
- Renal Cell Carcinoma
- Skeletal Muscle Atrophy
- Metastatic Breast Cancer
- Quality of Life
- Muscle Regeneration
- Metastatic
- Cost of Care
- BCR-ABL
- Cost-effectiveness Analysis
- Breast Cancer
- EGFR Mutations
- Chemotherapy-Induced Peripheral Neuropathy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Quality of Life482 topics
- Metastatic Breast Cancer452 topics
- Muscle Regeneration441 topic
- Skeletal Muscle Atrophy441 topic
- Metastatic341 topic
- Renal Cell Carcinoma341 topic
- Cost of Care321 topic
- Financial Toxicity321 topic
- BCR-ABL281 topic
- Imatinib281 topic
- Cost-effectiveness Analysis261 topic
- Health Utility Measures261 topic
- Breast Cancer231 topic
- CDK4/6 Inhibitors231 topic
- EGFR Mutations231 topic
- Targeted Therapy231 topic
- Chemotherapy-Induced Peripheral Neuropathy221 topic
- Taxanes221 topic
Where does James Edward Signorovitch work?
James Edward Signorovitch's main affiliation in the publication record is Analysis Group (United States), United States.
How many publications and citations does James Edward Signorovitch have?
OpenAlex counts 439 works and 8,786 citations for James Edward Signorovitch, an h-index of 44, ranking #877,111 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about James Edward Signorovitch. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.